TRPS1 function beyond breast: A retrospective immunohistochemical study on non‐breast cytology specimens

Author:

Ali Amr1ORCID,Geetha Saroja1,Wu Dongling1,Chau Karen1,Karam Priyanka1,Khutti Seema1ORCID,Fayyaz Silvat‐Sheik1,Das Kasturi1ORCID,Gimenez Cecilia1,Rosca Oana C.1

Affiliation:

1. Department of Pathology and Laboratory Medicine Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead New York USA

Abstract

AbstractIntroductionTrichorhinophalangeal syndrome type 1 (TRPS1) has emerged as a reliable immunohistochemistry (IHC) marker for identifying breast origin in metastatic carcinomas. This study investigates the utility of TRPS1 IHC in non‐breast cytology specimens.Materials and MethodsA retrospective search of our pathology database for the year 2021 identified fluids (pleural and peritoneal) and liver, lung and bone fine needle aspirations (FNAs) with surgical follow‐up confirming non‐breast metastatic carcinomas. Cell blocks from cases with sufficient neoplastic cells underwent immunostaining using a rabbit polyclonal antibody against human TRPS1. Cases lacking tumor on deeper levels after the original work‐up were excluded from the study. Two pathologists independently interpreted the TRPS1 staining.ResultsOf 136 cases assessed, 31 (22.79%) exhibited positive TRPS1 staining, while 105 (77.21%) were nonreactive. Positivity rates were observed in tumors of Mullerian cell origin, gastrointestinal tract (GIT), and lung origin at 28.85%, 25%, and 21.57%, respectively. Of the tumors of Mullerian cell origin 10 (66.67%) were serous carcinomas, 4 (26.67%) were endometrioid carcinomas, and one (6.67%) was a clear cell carcinoma. Lung tumors comprised seven (63.64%) squamous cell carcinomas and four (36.36%) adenocarcinomas, while the gastrointestinal tumors consisted of 14 (80%) adenocarcinomas and one (20%) squamous cell carcinoma.ConclusionsAlthough recognized as a sensitive marker for mammary carcinomas, TRPS1 immunostaining was also detected in Mullerian, lung, and GIT carcinomas. This highlights the significance of being cautious when depending solely on TRPS1 immunostaining to distinguish metastatic breast tumors.

Publisher

Wiley

Reference18 articles.

1. AlkabbanFM FergusonT.Breast Cancer.StatPearls. StatPearls Publishing Copyright © 2023 StatPearls Publishing LLC.2023.

2. Breast cancer;Metastatic PO;Radiol Technol,2017

3. Triple-Negative Breast Cancer

4. Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3